...
首页> 外文期刊>Frontiers in Pediatrics >Echocardiographic Diagnosis and Hemodynamic Evaluation of Patent Ductus Arteriosus in Extremely Low Gestational Age Newborn (ELGAN) Infants
【24h】

Echocardiographic Diagnosis and Hemodynamic Evaluation of Patent Ductus Arteriosus in Extremely Low Gestational Age Newborn (ELGAN) Infants

机译:超强孕龄(泻药)婴幼儿在极低孕龄阶段癌症的超声心动图诊断和血流动力学评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Persistent Patent ductus arteriosus (PDA) is a common finding in extremely low gestational age newborn infants and its prevalence is inversely proportional to the gestational age. The presence of a persistent PDA is associated with increased mortality and several significant morbidities including intraventricular hemorrhage, pulmonary hemorrhage, necrotizing enterocolitis and chronic lung disease or bronchopulmonary dysplasia. However, treating PDA has not been demonstrated to have beneficial impact on the long term outcomes. Currently there is no consensus on whether to treat the PDA or not, and if treat, when to treat and how to treat. The echocardiography is the investigation of choice to diagnose PDA, estimating the magnitude of shunt volume and assessing its hemodynamic significance, and to exclude/diagnose any associated congenital heart defect before any intervention. Various echocardiographic parameters and staging / scoring systems have been described to help the clincians making the clinical decisions and some of theses scoring systems are quite complex to apply in a busy day to day clinical practice. This concised review paper is focused to help the clinicians in making a clinical decision based upon clincial and echocardiography parameters. Hence, only the parameters which are commonly used and helpful in making the clinical decisions in day to day clincial practice have been described in this paper.
机译:持续的专利导管蛛网(PDA)是在极低的孕龄新生儿的常见发现,其患病率与孕龄成反比。持续PDA的存在与增加的死亡率增加和几种显着的病理,包括腔内出血,肺动脉出血,坏死性小肠结肠炎和慢性肺病或支气管肺病发育不良。然而,治疗PDA对长期结果有益影响。目前,无论是对治疗PDA还是治疗,何时对待以及如何治疗时,没有达成共识。超声心动图是对诊断PDA的选择,估计分流体积的大小并评估其血液动力学意义的选择,并在任何干预之前排除/诊断任何相关的先天性心脏缺陷。已经描述了各种超声心动图参数和分期/评分系统,以帮助临床决策,一些评分系统在繁忙的日常临床实践中申请很复杂。这份综合审查纸部专注于帮助临床医生基于薄片和超声心动图参数进行临床决策。因此,本文仅描述了在日常生活中常用和有用的参数,以便在日常林实实践中进行临床决策。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号